| Patents for A61K 38 - Medicinal preparations containing peptides (316,240) |
|---|
| 02/19/2009 | US20090048160 Antimicrobial activity of bovine bactericidal/permeability-increasing protein (BPI)-derived peptides against Gram-negative bacterial mastitis isolates |
| 02/19/2009 | US20090048159 Kit for treating a health condition by inducing translocation of a calreticulin protein to a cellular membrane |
| 02/19/2009 | US20090048158 Insulin-Like Growth Factor Binding Protein-4 Compounds and Methods for Inhibiting Angiogenesis and Tumor Growth in Mammalian Cells |
| 02/19/2009 | US20090048157 Use of organic compounds |
| 02/19/2009 | US20090048156 Hdac inhibitors and hormone targeted drugs for the treatment of cancer |
| 02/19/2009 | US20090048155 Methods for preventing and treating tissue injury and sepsis associated with Yersinia pestis infection |
| 02/19/2009 | US20090048154 Compositions and Methods for Treating Diabetes |
| 02/19/2009 | US20090048153 Composition for treating sulfur mustard toxicity and methods of using same |
| 02/19/2009 | US20090048152 Systems and Methods for Glycemic Control During Pump Disconnection |
| 02/19/2009 | US20090048151 PEG-Poly(Ortho Ester) Graft Copolymers and Pharmaceutical Compositions |
| 02/19/2009 | US20090048150 Materials and Methods for the Detection of Nitrated Fibrinogen |
| 02/19/2009 | US20090048149 Antagonists of the bradykinin B1 receptor |
| 02/19/2009 | US20090048148 Compositions and methods for therapeutic use |
| 02/19/2009 | US20090048147 Nitrogen-based linkers for attaching modifying groups to polypeptides and other macromolecules |
| 02/19/2009 | US20090048146 Use of agents that upregulate crystallin expression in the retina and optic nerve head |
| 02/19/2009 | US20090048145 In situ hardening paste, its manufacturing and use |
| 02/19/2009 | US20090047741 Compositions and methods comprising a ligand of chemerin R |
| 02/19/2009 | US20090047735 Antibodies Against Human G-Protein Chemokine Receptor (CCR5) HDGNR10 |
| 02/19/2009 | US20090047687 Indane Acetic Acid Derivatives and Their Use as Pharmaceutical Agents, Intermediates, and Method of Preparation |
| 02/19/2009 | US20090047361 Combination of Limited Nutrients and Enhanced Dietary Antioxidants To Impart Improved Kidney Health |
| 02/19/2009 | US20090047358 Phospholipid-based powders for drug delivery |
| 02/19/2009 | US20090047349 Drug delivery device |
| 02/19/2009 | US20090047348 Poly(organophosphazene) hydrogels for drug delivery, preparation method thereof and use thereof |
| 02/19/2009 | US20090047340 Liposomal reduced glutathione and 1-arginine, including with other ingredient(s), capable of multipath administration for reversal and prevention of obesity and for mitochondrial biogenesis |
| 02/19/2009 | US20090047339 Polynucleotides encoding antigenic HIV type C polypeptides, polypeptides and uses thereof |
| 02/19/2009 | US20090047335 Anti-angiogenic peptides and methods of use thereof |
| 02/19/2009 | US20090047318 Nanoparticle-coated medical devices and formulations for treating vascular disease |
| 02/19/2009 | US20090047306 Adjuvant compositions |
| 02/19/2009 | US20090047299 Modified alpha-galactosyl ceramides for staining and stimulating natural killer t cells |
| 02/19/2009 | US20090047296 Antibodies conjugated to Auristatin analogs via a maleimidocaproyl lingages; for treating cancer, autoimmune diseases and infectious diseases |
| 02/19/2009 | US20090047292 Graft rejection suppressors |
| 02/19/2009 | US20090047286 H2n3 influenza a viruses and methods of use |
| 02/19/2009 | US20090047284 Methods and compositions for PDGF-C activation and inhibition |
| 02/19/2009 | US20090047283 Compounds and methods for treatment and diagnosis of chlamydial infection |
| 02/19/2009 | US20090047282 Prophylactic/Therapeutic Agent for Cancer |
| 02/19/2009 | US20090047281 Activin-ActRII antagonists and uses for increasing red blood cell levels |
| 02/19/2009 | US20090047276 Methods for increasing cell or tissue regeneration in a vertebrate subject |
| 02/19/2009 | US20090047275 Modulating calvarial osteoblast differentiation; fracture repair |
| 02/19/2009 | US20090047273 Method For Production of Recombinant Human Thrombin ['644] |
| 02/19/2009 | US20090047272 Compositions with Modified Nucleases Targeted to Viral Nucleic Acids and Methods of Use for Prevention and Treatment of Viral Diseases |
| 02/19/2009 | US20090047271 Stable recombinant adenosine deaminase |
| 02/19/2009 | US20090047270 Enzymatic anticancer therapy |
| 02/19/2009 | US20090047269 Metabolomic cancer targets |
| 02/19/2009 | US20090047268 Compositions of prokaryotic phenylalanine ammonia-lyase and methods of treating cancer using compositions thereof |
| 02/19/2009 | US20090047267 Process for the Preparation of A Non-Corrosive Base Solution And Methods Of Using Same |
| 02/19/2009 | US20090047266 Lipases for Pharmaceutical Use |
| 02/19/2009 | US20090047265 Compositions of prokaryotic phenylalanine ammonia-lyase and methods of treating cancer using compositions thereof |
| 02/19/2009 | US20090047258 Compositions and methods for reversing age-related changes in extracellular matrix proteins |
| 02/19/2009 | US20090047256 Biodegradable Elastomers |
| 02/19/2009 | US20090047254 Bacteriophage and their uses |
| 02/19/2009 | US20090047252 Antiviral compounds |
| 02/19/2009 | US20090047251 Conjugates of hydroxyalkyl starch and a protein |
| 02/19/2009 | US20090047250 Methods for treating or preventing neuroinflammation or autoimmune diseases |
| 02/19/2009 | US20090047249 Modulators of toll-like receptor 7 |
| 02/19/2009 | US20090047248 Triazolyl macrocyclic hepatitis c serine protease inhibitors |
| 02/19/2009 | US20090047247 Pyrrolidine Derivatives |
| 02/19/2009 | US20090047246 Novel inhibitors of hepatitis c virus replication |
| 02/19/2009 | US20090047245 Prognostic chronic hepatitis C biomarkers |
| 02/19/2009 | US20090047244 Macrocyclic serine protease inhibitors i |
| 02/19/2009 | US20090047243 Combinations for the treatment of b-cell proliferative disorders |
| 02/19/2009 | US20090047242 Conditioned blood composition and method for its production |
| 02/19/2009 | US20090047241 Il-12 facilitates both the recovery of endogenous hematopoiesis and the engraftment of stem cells after ionizing radiation |
| 02/19/2009 | US20090047240 Chaperonin 10-induced immunomodulation |
| 02/19/2009 | US20090047238 Novel Spirotropane Compounds And Methods For The Modulation Of Chemokine Receptor Activity |
| 02/19/2009 | US20090047234 Compositions for nasal delivery |
| 02/19/2009 | US20090047232 Formulation and method for treating animal waste |
| 02/19/2009 | US20090047217 Polynucleotides Encoding Members of the Human B Lymphocyte Activation Antigen B7 Family and Polypeptides Encoded Thereby |
| 02/19/2009 | US20090047210 Cleavage of VEGF and VEGF receptor by wildtype and mutant MT-SP1 |
| 02/19/2009 | DE102007038015A1 Verwendung eines Neurotoxins Use of a neurotoxin |
| 02/19/2009 | CA2733681A1 A composition based on perhydrosqualene and collagen-polyvinylpyrrolidone for filling minor cutaneous depressions |
| 02/19/2009 | CA2733672A1 Tumor cell-derived microvesicles |
| 02/19/2009 | CA2700923A1 Novel targets and compounds for therapeutic intervention of hiv infection |
| 02/19/2009 | CA2696177A1 Repair of lesions in cartilage and bone using a chondro-regulative matrix |
| 02/19/2009 | CA2695988A1 Treatment of atherosclerosis |
| 02/19/2009 | CA2695981A1 Vhz for diagnosis and treatment of cancer |
| 02/19/2009 | CA2695970A1 Insulin analogues with an acyl and aklylene glycol moiety |
| 02/19/2009 | CA2695374A1 Compositions and methods for modifying properties of biologically active polypeptides |
| 02/19/2009 | CA2694863A1 Agents and methods for modulating macrophage inhibitory cytokine (mic-1) activity |
| 02/19/2009 | CA2687024A1 Targeting host proteinases as a therapeutic strategy against viral and bacterial pathogens |
| 02/19/2009 | CA2683748A1 Mutants of cholesterol-dependent cytolysins and uses thereof |
| 02/18/2009 | EP2026073A1 Diagnostics and therapeutics for macular degeneration-related disorders |
| 02/18/2009 | EP2025752A2 Antisense oligonucleotides for the inhibition of expression of type I procollagen |
| 02/18/2009 | EP2025745A1 Method for preparing cells for engraftment |
| 02/18/2009 | EP2025684A1 Glucagon analogues |
| 02/18/2009 | EP2025682A2 Human endokine alpha |
| 02/18/2009 | EP2025345A1 KIM-1 antagonists and use to modulate immune system |
| 02/18/2009 | EP2025344A1 Melanoma Therapy |
| 02/18/2009 | EP2025343A1 A short-chain peptide anti-cancer drug and its use |
| 02/18/2009 | EP2025342A1 Therapeutic agent or development inhibitor of polyglutamine disease |
| 02/18/2009 | EP2024748A2 Monoclonal anti-annexin a3 antibodies for the detection of prostate carcinoma |
| 02/18/2009 | EP2024389A2 Imaging agent |
| 02/18/2009 | EP2024387A1 Peptide substance enhancing capillaries resistance, pharmaceutical composition on its base and method of its application |
| 02/18/2009 | EP2024386A2 Use of proteins and peptides of the tgf-beta superfamily for purification and therapeutic methods |
| 02/18/2009 | EP2024380A2 Substituted aryl piperidinylalkynyladenosines as a2ar agonists |
| 02/18/2009 | EP2023959A1 Polyethylene glycol-interferon alpha conjugate |
| 02/18/2009 | EP2023950A2 Urodilatin cancer treatment |
| 02/18/2009 | EP2023949A2 Compositions and methods for convection enhanced delivery of high molecular weight neurotherapeutics |
| 02/18/2009 | EP2023948A1 Use of cyclosporin a or melle4-cyclosporin for the treatment of acute myocardial infarction |
| 02/18/2009 | EP2023947A2 Composition and method for increasing cell permeability of a compound |
| 02/18/2009 | EP2023946A1 Inhibition of gliotoxin |